SCHEMBL5260904

SCHEMBL5260904

CCOC(=O)CN1CCN(c2nc(=O)c3c(C)c(OC)c(OC)cc3[nH]2)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 1/20 0.39
▸ HTR2C P28335 1/20 0.39
▸ ALDH1A1 P00352 6/20 0.38
▸ GAA P10253 1/20 0.38
▸ KDM4E B2RXH2 4/20 0.37
▸ HSD17B10 Q99714 2/20 0.37
▸ HPGD P15428 1/20 0.37
▸ TP53 P04637 2/20 0.37
▸ PDE3B Q13370 1/20 0.37
▸ PDE3A Q14432 1/20 0.37
▸ TNF P01375 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ DCTPP1 Q9H773 1/20 0.35
▸ POLB P06746 2/20 0.35
▸ TUBB4A P04350 1/20 0.35
▸ TUBB P07437 1/20 0.35
▸ TUBA3C P0DPH7 1/20 0.35
▸ TUBA1B P68363 1/20 0.35
▸ TUBA4A P68366 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5264229 0.93 ALDH1A1 (0.39) HTR1AHTR2CALDH1A1GAAKDM4E
SCHEMBL5264473 0.87 MAPT (0.44) HTR1AALDH1A1GAAKDM4EHSD17B10
SCHEMBL5262020 0.82 LMNA (0.39) ALDH1A1KDM4EMEN1KMT2APOLB
SCHEMBL5259770 0.81 CDK9 (0.42) ALDH1A1GAACASP7CCNT1CDK9
SCHEMBL5260022 0.81 MAPT (0.45) HTR1AALDH1A1GAAKDM4EHSD17B10
SCHEMBL5263193 0.79 KDM4E (0.48) ALDH1A1GAAKDM4EHSD17B10TP53
SCHEMBL5261299 0.78 TNKS (0.37) MEN1KMT2ADCTPP1TSHRLMNA
SCHEMBL5260416 0.78 KDM4E (0.40) ALDH1A1KDM4EHSD17B10HPGDTP53
SCHEMBL5263885 0.77 DCTPP1 (0.36) ALDH1A1GAAKDM4EMEN1KMT2A
SCHEMBL5263197 0.77 CFD (0.43) ALDH1A1KDM4EHSD17B10MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050124607-A1 5-Substituted quinazolinone compounds useful as alpha 1A/B adrenergic receptor antagonists ROCHE PALO ALTO LLC 2005-06-09 — — US claimed
EP-1644343-B1 5-SUBSTITUTED QUINAZOLINONE DERIVATIVES HOFFMANN LA ROCHE (CH) 2007-07-04 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050124607-A1 5-Substituted quinazolinone compounds useful as alpha 1A/B adrenergic receptor antagonists ADRB1, ADRA1B, ADRB2 HTR1A 75/4885HTR2C 241/4885ALDH1A1 318/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback